Literature DB >> 3609073

Pharmacokinetic aspects of sulfobromophthalein transport after diethyl maleate pretreatment in rats.

J González, M J Aza, E Mariño, A Esteller.   

Abstract

The pharmacokinetics of sulfobromophthalein was studied in the rat after depletion of hepatic glutathione levels induced by intraperitoneal administration of diethyl maleate (4.0 mmol/kg). After an intravenous bolus injection of sulphobromophthalein (120 mumol/kg) a biexponential plasma decay was found both in control and diethyl maleate pretreated rats. The initial plasma clearance Cl12 was not modified by diethyl maleate administration. The rate constant of biliary excretion K23 was significantly lowered in diethyl maleate pretreated rats, which could by explained by the change in the biliary excretory process. The cumulative biliary excretion of sulphobromophthalein was decreased by about 50% following diethyl maleate injection, with a reduction of the percentage of conjugated dye excreted into bile.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3609073     DOI: 10.1007/BF03189855

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  24 in total

1.  Changes in biliary secretion and lactate metabolism induced by diethyl maleate in rabbits.

Authors:  R Jimenez; J Gonzalez; C Arizmendi; J Fuertes; J M Medina; A Esteller
Journal:  Biochem Pharmacol       Date:  1986-12-01       Impact factor: 5.858

2.  Inhibition by bromsulphthalein of the biliary excretion of its glutathion conjugate.

Authors:  Z Gregus; E Fischer; F Varga
Journal:  Biochem Pharmacol       Date:  1977-10-15       Impact factor: 5.858

3.  Biliary excretion of bromsulphthalein and glutathione conjugate of bromsulphthalein in rats pretreated with diethyl maleate.

Authors:  F Varga; E Fischer; T S Szily
Journal:  Biochem Pharmacol       Date:  1974-09-15       Impact factor: 5.858

4.  Compartmental analysis of sulfobromophthalein transport in normal patients and patients with hepatic dysfunction.

Authors:  S H Quarfordt; H L Hilderman; D Valle; E Waddell
Journal:  Gastroenterology       Date:  1971-02       Impact factor: 22.682

5.  The effect of some carbonyl compounds on rat liver glutathione levels.

Authors:  E Boyland; L F Chasseaud
Journal:  Biochem Pharmacol       Date:  1970-04       Impact factor: 5.858

6.  Extended least squares nonlinear regression: a possible solution to the "choice of weights" problem in analysis of individual pharmacokinetic data.

Authors:  C C Peck; S L Beal; L B Sheiner; A I Nichols
Journal:  J Pharmacokinet Biopharm       Date:  1984-10

Review 7.  Chemical depletion of glutathione in vivo.

Authors:  J L Plummer; B R Smith; H Sies; J R Bend
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

8.  Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine.

Authors:  O W Griffith
Journal:  Anal Biochem       Date:  1980-07-15       Impact factor: 3.365

9.  Enzyme-catalysed conjugations of glutathione with unsaturated compounds.

Authors:  E Boyland; L F Chasseaud
Journal:  Biochem J       Date:  1967-07       Impact factor: 3.857

10.  Choleresis associated with metabolism and biliary excretion of diethyl maleate in the rat and dog.

Authors:  J L Barnhart; B Combes
Journal:  J Pharmacol Exp Ther       Date:  1978-09       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.